Five researchers elected to American Society for Clinical Investigation

Ash Alizadeh, Maximilian Diehn, Brian Feldman, Aida Habtezion and Ravindra Majeti were elected to the medical honor society.

Five faculty members at the School of Medicine have been elected members of the American Society for Clinical Investigation, an honor society for physician-scientists that recognizes their research accomplishments.

Following are the new Stanford members and a brief description of their work:

  • Ash Alizadeh, MD, PhD, is an assistant professor of oncology. His research uses genomics, molecular genetics and computational biology to understand the behavior of tumors with the goal of developing improved therapies.  
  • Maximilian Diehn, MD, PhD, is an assistant professor of radiation oncology. His research interests include lung cancer biology and the development of genomics-based, predictive and prognostic biomarkers, with a focus on circulating nucleic acids. 
  • Brian Feldman, MD, PhD, is an assistant professor of pediatrics. His research examines the relationship between hormones and stem cells with the goal of developing therapies for conditions such as diabetes, cancer and sarcopenia.
  • Aida Habtezion, MD, is an assistant professor of medicine. Her research focuses on understanding the relationship between the immune system and conditions such as pancreatitis and inflammatory bowel disease, with the goal of developing new therapies.
  • Ravindra Majeti, MD, PhD, is an associate professor of medicine. His research examines the role of stem cells in acute myeloid leukemia, with the goal of improving clinical outcomes.


Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.